Symptoms & Disease Progression of AVED
At a Glance
AVED can progressively worsen balance, sensation, speech, and mobility without treatment, but consistent high-dose vitamin E often slows or stabilizes decline. Some coordination or speech may improve, although established nerve damage may remain.
Without treatment, Ataxia with Vitamin E Deficiency (AVED) is a progressive condition. Because the brain and nerves are deprived of essential antioxidant protection, damage accumulates over time, leading to worsening coordination and mobility [1][2]. However, the defining characteristic of AVED is its remarkable response to treatment: while established damage may persist, consistent high-dose vitamin E can significantly slow or stabilize the disease [3][4].
Primary Neurological Symptoms
The symptoms of AVED primarily reflect damage to the cerebellum (the brain’s coordination center) and the sensory nerves in the spinal cord [5].
- Gait Ataxia and Clumsiness: This is usually the first sign. It often begins as subtle unsteadiness or a tendency to trip and fall more often than others [6][2].
- Loss of Proprioception and Vibration: You may lose the ability to feel where your limbs are located without looking at them (proprioception) or feel the vibration of a tuning fork against your skin [1][7]. This makes walking in the dark or on uneven surfaces particularly difficult.
- Dysarthria: Damage to the nerves controlling speech can lead to slurred, slow, or “scanning” speech patterns [6].
- Areflexia: During a physical exam, a doctor may find that your deep-tendon reflexes (like the “knee-jerk”) are diminished or completely absent [1].
- Involuntary Movements: Some people experience head titubation (a rhythmic nodding or shaking of the head), tremors, or dystonia (involuntary muscle contractions that cause twisting movements) [6][8].
Extra-Neurological Symptoms
While the nervous system is the primary target, AVED can affect other parts of the body. These “extra-neurological” symptoms are important to monitor during regular check-ups.
- Skeletal Changes: Some patients with AVED develop scoliosis (a sideways curve of the spine) or foot deformities, such as high arches [6]. These are often secondary to the muscle weakness and nerve damage caused by the ataxia.
- Retinal Issues: A specific type of eye condition called retinopathy can occur. This may involve patchy areas of damage on the retina (the back of the eye) that can resemble retinitis pigmentosa [9][10].
- Cardiovascular and Systemic Health: While isolated reports in small families have noted premature hardening of the arteries (atherosclerosis) or heart disease, it is not an established defining feature of AVED for all patients [11]. Unlike Friedreich’s Ataxia, standard annual heart screenings are not universally required unless indicated by symptoms or family history.
The Overlap with Friedreich’s Ataxia (FRDA)
AVED is often called a “Friedreich’s Ataxia-like” syndrome because the two conditions look almost identical during a clinical exam [12]. Both involve progressive balance issues, speech changes, and a loss of reflexes [13].
The critical difference is the cause:
- FRDA is caused by a problem with the FXN gene and the protein frataxin [14]. It often involves significant heart complications (hypertrophic cardiomyopathy) and a higher risk of diabetes [15].
- AVED is caused by the TTPA gene and a vitamin E transport defect [1].
Because AVED is treatable and FRDA is managed differently, doctors must use specific genetic testing and vitamin E blood tests to tell them apart [12][16].
Disease Progression: With vs. Without Treatment
The speed at which AVED progresses varies. Symptoms typically start between ages 5 and 15, but some people are not diagnosed until adulthood [1][4].
| Feature | Without Treatment | With High-Dose Vitamin E |
|---|---|---|
| Gait/Walking | Progressively worsens; may lead to mobility aid use [6]. | Often stabilizes or slows progression [3]. |
| Nerve Damage | Continues to accumulate [2]. | Progression is significantly slowed [3]. |
| Symptom Reversal | None. | Some improvement in coordination/speech is possible, but established deficits may persist [4][6]. |
| Long-Term Outlook | Increasing disability over decades. | In one case report, a patient remained neurologically stable for over 30 years with adherence [3]. |
The takeaway for most families is one of cautious optimism: while vitamin E may not “undo” the damage that has already happened, it is an incredibly effective tool for protecting against future decline [3][2]. Consistent, lifelong treatment is the key to maintaining mobility and independence [17].
Common questions in this guide
What are the earliest signs of Ataxia with Vitamin E Deficiency?
How does AVED progress without treatment?
Can vitamin E treatment improve AVED symptoms?
How can doctors tell AVED apart from Friedreich's ataxia?
Can AVED affect the eyes, spine, or feet?
Are heart problems a common part of AVED?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Symptoms and signs
Which symptoms of AVED should I watch for?
Treatment outcomes
Could vitamin E slow changes in my coordination over time?
About testing
Would I need genetic testing or vitamin E blood tests to tell AVED apart from other conditions?
Get notified when new evidence is published on Ataxia with vitamin E deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Ataxia with vitamin e deficiency in norway.
Elkamil A, Johansen KK, Aasly J
Journal of movement disorders 2015; (8(1)):33-6 doi:10.14802/jmd.14030.
PMID: 25614784 - 2
Ataxia With Vitamin E Deficiency Syndrome and a Novel TTPA Variant: A Paired Case Report.
Baso G, Magri F, Sciacco M, et al.
Neurology. Genetics 2026; (12(3)):e200399 doi:10.1212/NXG.0000000000200399.
PMID: 42164107 - 3
First Recognized Patient with Genetic Vitamin E Deficiency Stable after 36 Years of Controlled Supplement Therapy.
Kohlschütter A, Finckh B, Nickel M, et al.
Neuro-degenerative diseases 2020; (20(1)):35-38 doi:10.1159/000508080.
PMID: 32623435 - 4
MNV-aware molecular characterization of a rare homozygous TTPA complex allele in ataxia with vitamin E deficiency.
Zaki-Dizaji M, Sarband MM
Molecular genetics and genomics : MGG 2026; (301(1)).
PMID: 42711446 - 5
The tocopherol transfer protein mediates vitamin E trafficking between cerebellar astrocytes and neurons.
Ulatowski L, Ghelfi M, West R, et al.
The Journal of biological chemistry 2022; (298(3)):101712 doi:10.1016/j.jbc.2022.101712.
PMID: 35150738 - 6
Analysis of clinical pedigree characteristics in Chinese patients with ataxia with vitamin E deficiency.
Lv P, Liu L, Hao Y, et al.
Molecular genetics and metabolism 2026; (148(4)):110167 doi:10.1016/j.ymgme.2026.110167.
PMID: 42259017 - 7
Ataxia due to vitamin E deficiency: A case report and updated review.
Thapa S, Shah S, Chand S, et al.
Clinical case reports 2022; (10(9)):e6303 doi:10.1002/ccr3.6303.
PMID: 36093469 - 8
Ataxia with Vitamin E Deficiency May Present with Cervical Dystonia.
Becker AE, Vargas W, Pearson TS
Tremor and other hyperkinetic movements (New York, N.Y.) 2016; (6()):374 doi:10.7916/D8B85820.
PMID: 27274910 - 9
Atypical retinopathy in ataxia with vitamin E deficiency: report of a sibship.
Abramowicz S, Dentel A, Chouraqui M, et al.
Neurogenetics 2024; (25(1)):33-38 doi:10.1007/s10048-023-00741-9.
PMID: 38105315 - 10
Syndromic retinitis pigmentosa.
Karuntu JS, Almushattat H, Nguyen XT, et al.
Progress in retinal and eye research 2025; (107()):101324 doi:10.1016/j.preteyeres.2024.101324.
PMID: 39733931 - 11
Familial vitamin E deficiency: Multiorgan complications support the adverse role of oxidative stress.
Trotta E, Bortolotti S, Fugazzotto G, et al.
Nutrition (Burbank, Los Angeles County, Calif.) 2019; (63-64()):57-60 doi:10.1016/j.nut.2018.11.012.
PMID: 30933726 - 12
A first description of ataxia with vitamin E deficiency associated with MT-TG gene mutation.
Maalej M, Kammoun F, Kharrat M, et al.
Acta neurologica Belgica 2021; (121(6)):1733-1740 doi:10.1007/s13760-020-01490-4.
PMID: 32979145 - 13
A Case of Ataxia with Isolated Vitamin E Deficiency Initially Diagnosed as Friedreich's Ataxia.
Bonello M, Ray P
Case reports in neurological medicine 2016; (2016()):8342653 doi:10.1155/2016/8342653.
PMID: 26989534 - 14
Assessing airway clearance dysfunction in Friedreich's ataxia: A focus on peak cough flow.
Smith BK, Coker MA, Liberati C, et al.
Journal of neuromuscular diseases 2026; 22143602261452334 doi:10.1177/22143602261452334.
PMID: 42253100 - 15
Characterizing cardiac phenotype in Friedreich's ataxia: The CARFA study.
Legrand L, Weinsaft JW, Pousset F, et al.
Archives of cardiovascular diseases 2022; (115(1)):17-28 doi:10.1016/j.acvd.2021.10.010.
PMID: 34920960 - 16
Friedreich's Ataxia: Clinical Presentation of a Compound Heterozygote Child with a Rare Nonsense Mutation and Comparison with Previously Published Cases.
Rao VK, DiDonato CJ, Larsen PD
Case reports in neurological medicine 2018; (2018()):8587203 doi:10.1155/2018/8587203.
PMID: 30159187 - 17
Ataxia with vitamin E deficiency in the Philippines : A case report of two siblings.
Tabuena MD, Morigaki R, Miyamoto R, et al.
The journal of medical investigation : JMI 2021; (68(3.4)):400-403 doi:10.2152/jmi.68.400.
PMID: 34759169
This page is for informational purposes only and does not constitute medical advice. A neurologist and your care team should interpret AVED symptoms, vitamin E levels, and genetic tests for your specific situation.